$58.78
arrow_drop_up0.58%Key Stats | |
---|---|
Open | $58.40 |
Prev. Close | $58.40 |
EPS | -3.76 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 58.30 | 59.99 |
52 Week Range | 25.75 | 55.78 |
Ratios | |
---|---|
EPS | -3.76 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Crinetics Pharmaceuticals exec sells shares worth over $645,000 - Investing.com
Forecasting The Future: 11 Analyst Projections For Crinetics Pharmaceuticals
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner